In late 2021 a new consensus report, The Management of Type 1 Diabetes in Adults, was published jointly by American Diabetes Association (in Diabetes Care) and European Study for Diabetes (EASD) (in Diabetologia). The report was developed by 14 content experts. The focus, interestingly, is on people 18 years of age and older.
Until recently the only ways to take insulin, other than using an insulin pump, was via traditional pens or vial and syringe. Due to engineering and technological innovation there’s a growing cadre of insulin delivery devices called connected insulin delivery devices. In this blog for T1D Exchange, I define “connected” devices and review the rationale for their need.
Precision medicine, precision nutrition – both terms and concepts for personalized health care are becoming popular. But do we know enough yet to apply these concepts, and related knowledge, to make personalized recommendations?
I was once again delighted to appear on the award-winning and well-known nutrition podcast, Sound Bites, hosted by fellow RDN and CDCES, Melissa Joy Dobbins. I appeared on this episode (#189) with Dr. John Sievenpiper, one of the smartest scientist/researchers today on the topic of added sugars and sugar substitutes
While there’s LOTS of talk about what are now referred to as Automated Insulin Delivery (AID) systems (rather than artificial pancreas systems), many people don’t fully understand how these devices will work and what they’ll actually accomplish. This blog written for the T1D Exchange, describes the evolution to AID systems, details the current and near-future devices in a related table and discusses the clinical and mental health benefits of AID systems.
For years I’ve heard the terms “FDA-approved,” “FDA-cleared,” and “510-k application,” associated with the review of medical devices at the U.S. FDA, but I wasn’t clear on their definitions.